Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Special Equities Group is a U.S. merchant banking and capital markets advisory firm focused on microcap and small public companies. The firm provides services including principal investments, PIPEs and registered direct financings, merchant banking, up-listings to national exchanges, underwritten public offerings, bought deals, M&A advisory, SPAC-related work, block trades, and corporate client services. It operates as a division of Dawson James for securities and brokerage services, while The Special Equities Group, LLC and Dawson James Securities, Inc. are presented as independent entities. Although the firm works with some healthcare and biotechnology clients through capital markets activity, it is not itself a biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Special Equities Group.